We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$5.52B
AUM Growth
+$541M
Cap. Flow
+$271M
Cap. Flow %
4.91%
Top 10 Hldgs %
44.98%
Holding
98
New
38
Increased
17
Reduced
16
Closed
26

Top Buys

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$420M
2
WBA
Walgreens Boots Alliance
WBA
+$179M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$158M
4
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$131M
5
SCHW
Charles Schwab
SCHW
+$130M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$206M
2
MDVN
MEDIVATION, INC.
MDVN
+$182M
3
PCP
PRECISION CASTPARTS CORP
PCP
+$158M
4
TNL icon
Travel + Leisure Co
TNL
+$136M
5
GILD icon
Gilead Sciences
GILD
+$131M

Sector Composition

Rank Sector Weight
1 Healthcare 46.4%
2 Communication Services 13.6%
3 Energy 5.28%
4 Financials 5.09%
5 Technology 4.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTA icon
51
Prothena Corp
PRTA
$448M
$20.8M 0.38%
+541,983
New +$17.5M
ANAC
52
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$20.5M 0.37%
1,026,745
-28,269
-3% -$548K
RPRX
53
DELISTED
Repros Therapeutics Inc.
RPRX
$19.8M 0.36%
1,114,462
-425,629
-28% -$8.24M
APC
54
DELISTED
Anadarko Petroleum
APC
$18M 0.33%
+212,833
New +$17.4M
MDVN
55
DELISTED
MEDIVATION, INC.
MDVN
$16.4M 0.3%
510,210
-4,929,508
-91% -$182M
BRKR icon
56
Bruker
BRKR
$9.4B
$16.2M 0.29%
711,052
-277,138
-28% -$6.04M
OCR
57
DELISTED
OMNICARE INC
OCR
$15.8M 0.29%
264,968
+141,540
+115% +$8.58M
TXMD icon
58
TherapeuticsMD
TXMD
$23.8M
$15.2M 0.28%
+48,315
New +$15.4M
CI icon
59
Cigna
CI
$78.4B
$14.2M 0.26%
+169,613
New +$14M
RVNC
60
DELISTED
Revance Therapeutics, Inc.
RVNC
$10.1M 0.18%
+320,903
New +$10M
KPTI icon
61
Karyopharm Therapeutics
KPTI
$155M
$9.56M 0.17%
20,639
-38,662
-65% -$19.6M
FRX
62
DELISTED
FOREST LABORATORIES INC
FRX
$7.66M 0.14%
+83,033
New +$6.7M
BLUE
63
DELISTED
bluebird bio
BLUE
$6.62M 0.12%
22,468
-254
-1% -$77K
MGNX icon
64
MacroGenics
MGNX
$233M
$5.82M 0.11%
209,212
+124,366
+147% +$4.39M
CX icon
65
Cemex
CX
$16.9B
$5.67M 0.1%
+524,747
New +$5.66M
RVTY icon
66
Revvity
RVTY
$12.6B
$5.25M 0.1%
+116,477
New +$5.11M
EIGR
67
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$4.59M 0.08%
+856
New +$4.05M
CSLT
68
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$2.04M 0.04%
+96,223
New +$2.79M
MYGN icon
69
Myriad Genetics
MYGN
$476M
$1.38M 0.03%
40,491
-365,612
-90% -$11.3M
SAVE
70
DELISTED
Spirit Airlines, Inc.
SAVE
$1.14M 0.02%
+19,264
New +$1.01M
TEVA icon
71
CALL
Teva Pharmaceuticals
TEVA
$40.4B
$570K 0.01%
+404,100
New +$18.7M
ADBE icon
72
Adobe
ADBE
$105B
– –
-1,849,097
Closed -$111M
AMT icon
73
American Tower
AMT
$83.5B
– –
-1,485,052
Closed -$119M
AMZN icon
74
Amazon
AMZN
$2.44T
– –
-10,332,780
Closed -$206M
BIDU icon
75
Baidu
BIDU
$35.7B
– –
-342,395
Closed -$60.9M
1 2
3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q1 2014 Portfolio in Review

As of Q1 2014, PFM Health Sciences held 98 positions worth $5.52B, up 11% from $4.97B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

PFM Health Sciences deployed $271M of net new capital in Q1 2014, opening 38 new positions and adding to 17 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 10,702,700 shares worth $439M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 40% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was MEDIVATION, INC., an estimated $182M trimmed.

  • PFM Health Sciences's largest Q1 2014 buy was iShares MSCI Emerging Markets ETF: 10,702,700 shares worth $439M.
  • PFM Health Sciences added most to Bausch Health in Q1 2014, an estimated $102M increase.
  • PFM Health Sciences's biggest Q1 2014 reduction was MEDIVATION, INC., cutting an estimated $182M.
  • PFM Health Sciences fully exited Amazon in Q1 2014, selling an estimated $206M.
  • PFM Health Sciences's ten largest holdings make up 45% of its $5.52B portfolio in Q1 2014.
  • PFM Health Sciences opened 38 new positions and closed 26 in Q1 2014.
  • PFM Health Sciences's portfolio value rose 11% quarter-over-quarter to $5.52B.

Based on PFM Health Sciences's 13F filing for Q1 2014, filed 15 May 2014.